3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3082B |
Molindone, Blood |
3082SP |
Molindone, Serum/Plasma |
3082U |
Molindone, Urine |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3226B |
Olanzapine and Metabolite, Blood |
3226FL |
Olanzapine, Fluid |
3226SP |
Olanzapine and Metabolite, Serum/Plasma |
3226TI |
Olanzapine, Tissue |
3265B |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Blood |
3265SP |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Serum/Plasma |
3310B |
Paraldehyde and Metabolite, Blood |
3310SP |
Paraldehyde and Metabolite, Serum/Plasma |
3310U |
Paraldehyde and Metabolite, Urine |
3320SP |
Paramethadione, Serum/Plasma |
3433SP |
Perampanel, Serum/Plasma |
3440B |
Perphenazine, Blood |
3440SP |
Perphenazine, Serum/Plasma |
3707B |
Phenylethylmalonamide, Blood |
3707SP |
Phenylethylmalonamide, Serum/Plasma |
3743B |
Phenytoin, Blood |
3743FL |
Phenytoin, Fluid |
3743SP |
Phenytoin, Serum/Plasma |
3743TI |
Phenytoin, Tissue |
3776B |
Pimozide, Blood |
3776SP |
Pimozide, Serum/Plasma |
3901SP |
Primidone, Serum/Plasma |